TONY MATHEWS
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism BRONXVILLE, NY NPI 1508201559
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NY Novo Nordisk AS All categories
General Payments — all program years on this page
$695.83
- Category: General Payments
- Program years: PY2022–2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $659.30 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.32 | 6 |
| Long term medical supply or device loan | $19.98 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $243.05 | 2 |
| SANOFI-AVENTIS U.S. LLC | $131.37 | 1 |
| Amgen Inc. | $121.84 | 1 |
| Lilly USA, LLC | $121.30 | 1 |
| Medtronic, Inc. | $21.76 | 1 |
| Abbott Laboratories | $19.98 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097650902 | Novo Nordisk Inc | $125.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097717550 | Novo Nordisk Inc | $118.05 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115909346 | Amgen Inc. | $121.84 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119350492 | Medtronic, Inc. | $21.76 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125414645 | Abbott Laboratories | $19.98 | 01/24/2024 | Long term medical supply or device loan | Undisputed | 01/23/2026 | View at CMS |
| 1135483695 | Lilly USA, LLC | $121.30 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139824622 | SANOFI-AVENTIS U.S. LLC | $131.37 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.